Dr. Beer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-6594
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 1996 - 1999
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1991 - 1996
- Johns Hopkins University School of MedicineClass of 1991
Certifications & Licensure
- OR State Medical License 1992 - 2025
- WA State Medical License 1994 - 1996
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2007-2014
- America's Top Doctors for Cancer Castle Connolly, 2006-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Docetaxel in Treating Patients With Stage IV Prostate Cancer Start of enrollment: 1998 Dec 01
- Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer Start of enrollment: 1999 Feb 01
- Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer Start of enrollment: 2000 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot Study.Kim C Ohaegbulam, Carl M Post, Paige E Farris, Mark Garzotto, Tomasz M Beer
American Journal of Clinical Oncology. 2025-02-01 - Tumor localization strategies of multi-cancer early detection tests: a quantitative assessment.Christopher Tyson, Kevin H Li, Xiting Cao, James M O'Brien, Elliot K Fishman
JNCI Cancer Spectrum. 2025-01-24 - Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.Neal Shore, Sarah M Nielsen, Edward D Esplin, Emmanuel S Antonarakis, Pedro C Barata
JCO Oncology Practice. 2024-12-19
Journal Articles
- Activity of Platinum-Based Chemotherapy in Patients with Advanced Prostate Cancer with and Without DNA Repair Gene AberrationsHimisha Beltran, Che-Kai Tsao, Tomasz M Beer, JAMA Network Open
- Development and Validation of a Prognostic Model for Overall Survival in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate CancerG Sonpavde, C S Higano, T M Beer, Annals of Oncology
Press Mentions
- What a New Blood Test Could Mean for You — and for the Future of Cancer DetectionNovember 15th, 2024
- Blood Tests That Detect Cancers Create Risks for Those Who Use ThemJune 10th, 2022
- New Blood Test from Biotech Firm Planning to Hire 400 in RTP Can Detect 50+ Types of CancerJune 8th, 2021
- Join now to see all
Grant Support
- Resistance And Response Mechanisms To Prostate Cancer TherapyNational Cancer Institute2006–2009
- Solid TumorsNational Cancer Institute2005–2009
- A Novel Vitamin D Target In Human Prostate CancerNational Cancer Institute2006–2007
- Acupuncture For HOT Flashes In Prostate Cancer PatientsNational Center For Research Resources2005
- Transdermal Estrogen In Androgen-Independent Prostate CancerNational Center For Research Resources2004–2005
- Acupuncture For HOT Flashes In Prostate Cancer PatientsNational Cancer Institute2003–2004
- Oregon Prostate Cancer Conference 2001National Cancer Institute2001–2003
- Pulse Calcitriol For Prostate Cancer PreventionNational Cancer Institute2000
- Calcitriol In Recurrent Prostate CancerNational Cancer Institute2000
Professional Memberships
- Member
- Fellow
Other Languages
- Polish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: